[40] demonstrated that treated NPC patients had lower CSF levels of the Aβ peptide Aβ1‐42, and the APP‐derived peptides sAPP‐α and sAPP‐β, suggesting that treatment may alter amyloid metabolism. This evidence concerns the gene APP and nasopharyngeal carcinoma.